Viking Therapeutics (VKTX) Misses Q4 EPS by 48c
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($1.38), $0.48 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.
Viking Therapeutics (NASDAQ: VKTX) reported Q4 EPS of ($1.38), $0.48 worse than the analyst estimate of ($0.90).
For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.